• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

德国女性及妇科医生对口服避孕药长周期治疗的态度

Attitude of German women and gynecologists towards long-cycle treatment with oral contraceptives.

作者信息

Wiegratz I, Hommel H H, Zimmermann T, Kuhl H

机构信息

Center of Obstetrics and Gynecology, University Hospital of Frankfurt, am Main, Frankfurt, Germany.

出版信息

Contraception. 2004 Jan;69(1):37-42. doi: 10.1016/j.contraception.2003.09.004.

DOI:10.1016/j.contraception.2003.09.004
PMID:14720618
Abstract

Long-cycle regimens with continuous use of oral contraceptives (OCs) for 3 or 6 months followed by a hormone-free interval of 7 days may reduce or prevent cycle-dependent and menses-related complaints. A representative survey carried out with 1195 German women in different age groups revealed that only 26-35% of the women aged between 15 and 49 years preferred monthly bleeding, while 37-46% wished to never bleed. The reasons for the refusal of regular menstruations were fewer severe menstrual complaints, better hygiene, higher quality of life, and less blood loss. Among the women who preferred regular withdrawal bleeding during the use of OCs, the main reasons were fear of pregnancy, infertility and adverse effects, and that menstruations were natural. Between 32% and 54% of the women would suppress menstruation sporadically and 11-14% for a longer period of time. After continuous treatment with a combination of 30 microg ethinyl estradiol and 2 mg dienogest for 6 months, the majority of women preferred the long-cycle regimen as compared to the conventional OC regimen despite a higher rate of irregular bleeding. Bleeding occurred primarily in first-time users of OC, particularly during the administration of the second OC pack. A survey carried out with German gynecologists revealed that most physicians prescribed extended OC cycles primarily for medical reasons, e.g., dysmenorrhea, hypermenorrhea, endometriosis and premenstrual dysphoric disorder. The gynecologists preferred a regimen with three packs of extended use of OCs.

摘要

连续服用口服避孕药(OCs)3个月或6个月,随后有7天无激素间隔期的长周期方案,可能会减少或预防与月经周期和月经相关的不适。一项对1195名不同年龄组德国女性进行的代表性调查显示,在15至49岁的女性中,只有26% - 35%的女性更喜欢每月来月经,而37% - 46%的女性希望永远不来月经。拒绝规律月经的原因包括严重月经不适较少、卫生状况更好、生活质量更高以及失血更少。在使用OCs期间更喜欢规律撤退性出血的女性中,主要原因是担心怀孕、不孕和不良反应,以及认为月经是自然现象。32%至54%的女性会偶尔抑制月经,11% - 14%的女性会在较长时间内抑制月经。在连续6个月使用30微克炔雌醇和2毫克地诺孕素联合治疗后,尽管不规则出血率较高,但与传统OC方案相比,大多数女性更喜欢长周期方案。出血主要发生在首次使用OCs的女性中,尤其是在服用第二包OCs期间。一项对德国妇科医生进行的调查显示,大多数医生主要出于医学原因,如痛经、月经过多、子宫内膜异位症和经前烦躁障碍,而开出延长OC周期的处方。妇科医生更喜欢使用三包延长使用期OCs的方案。

相似文献

1
Attitude of German women and gynecologists towards long-cycle treatment with oral contraceptives.德国女性及妇科医生对口服避孕药长周期治疗的态度
Contraception. 2004 Jan;69(1):37-42. doi: 10.1016/j.contraception.2003.09.004.
2
Long-cycle treatment with oral contraceptives.口服避孕药的长期治疗。
Drugs. 2004;64(21):2447-62. doi: 10.2165/00003495-200464210-00006.
3
Postponement of withdrawal bleeding in women using low-dose combined oral contraceptives.使用低剂量复方口服避孕药的女性撤退性出血延迟
Contraception. 1987 Mar;35(3):199-205. doi: 10.1016/0010-7824(87)90022-9.
4
Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel.基于雌二醇的口服避孕药的出血模式和周期控制:雌二醇戊酸酯/地诺孕素与炔雌醇/左炔诺孕酮的 7 个周期随机对照试验。
Contraception. 2009 Nov;80(5):436-44. doi: 10.1016/j.contraception.2009.03.018. Epub 2009 May 13.
5
Attitudes, knowledge and prescribing habits of Brazilian gynecologists regarding extended-cycle oral contraceptives.巴西妇科医生对延长周期口服避孕药的态度、知识和处方习惯。
Gynecol Endocrinol. 2013 Dec;29(12):1071-4. doi: 10.3109/09513590.2013.831833. Epub 2013 Sep 3.
6
Cycle control and side effects of a new combiphasic oral contraceptive regimen.一种新型复方双相口服避孕药方案的周期控制及副作用
Arzneimittelforschung. 1994 Jul;44(7):877-9.
7
Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use.与生殖状态、口服避孕药使用及激素替代疗法使用相关的月经出血的偏好频率和特征。
Contraception. 1999 Jun;59(6):357-62. doi: 10.1016/s0010-7824(99)00043-8.
8
The clinical rationale for menses-free contraception.无月经避孕的临床理论依据。
J Womens Health (Larchmt). 2007 Oct;16(8):1171-80. doi: 10.1089/jwh.2007.0332.
9
Prospective, open-label, noncomparative study to assess cycle control, safety and acceptability of a new oral contraceptive containing gestodene 60 microg and ethinylestradiol 15 microg (Minesse).一项前瞻性、开放标签、非对照研究,旨在评估一种含有60微克孕二烯酮和15微克炔雌醇的新型口服避孕药(米内斯)的周期控制、安全性和可接受性。
Contraception. 2006 Jan;73(1):30-3. doi: 10.1016/j.contraception.2005.06.057. Epub 2005 Nov 16.
10
A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low dose oral contraceptive containing 20 micrograms ethinyl estradiol and 100 micrograms levonorgestrel over six treatment cycles.一项多中心、非对照临床研究,旨在评估一种含20微克炔雌醇和100微克左炔诺孕酮的新型低剂量口服避孕药在六个治疗周期中的避孕效果、月经周期控制情况及安全性。
Contraception. 1997 Nov;56(5):285-90. doi: 10.1016/s0010-7824(97)00157-1.

引用本文的文献

1
Bleeding Patterns of Oral Contraceptives with a Cyclic Dosing Regimen: An Overview.具有周期性给药方案的口服避孕药的出血模式:综述
J Clin Med. 2022 Aug 8;11(15):4634. doi: 10.3390/jcm11154634.
2
Patient Experiences of Health Care Providers in Premenstrual Dysphoric Disorder: Examining the Role of Provider Specialty.经前期烦躁障碍患者对医护人员的体验:探究提供者专业的作用。
J Womens Health (Larchmt). 2022 Jan;31(1):100-109. doi: 10.1089/jwh.2020.8797. Epub 2021 Apr 1.
3
There might be blood: a scoping review on women's responses to contraceptive-induced menstrual bleeding changes.
可能会有出血:关于女性对避孕引起的月经出血变化反应的范围综述。
Reprod Health. 2018 Jun 26;15(1):114. doi: 10.1186/s12978-018-0561-0.
4
Extended regimen combined oral contraception: A review of evolving concepts and acceptance by women and clinicians.延长疗程复方口服避孕药:对不断演变的概念以及女性和临床医生接受度的综述
Eur J Contracept Reprod Health Care. 2016;21(2):106-15. doi: 10.3109/13625187.2015.1107894. Epub 2015 Nov 17.
5
Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception.复方激素避孕药连续或延长周期使用与周期性使用用于避孕的比较。
Cochrane Database Syst Rev. 2014 Jul 29;2014(7):CD004695. doi: 10.1002/14651858.CD004695.pub3.
6
Menstrual suppression: current perspectives.月经抑制:当前的观点。
Int J Womens Health. 2014 Jun 23;6:631-7. doi: 10.2147/IJWH.S46680. eCollection 2014.
7
Use of hormonal contraceptives to control menstrual bleeding: attitudes and practice of Brazilian gynecologists.使用激素避孕药控制月经出血:巴西妇科医生的态度和实践。
Int J Womens Health. 2013 Nov 27;5:795-801. doi: 10.2147/IJWH.S52086. eCollection 2013.
8
Characterisation of the pharmacokinetics of ethinylestradiol and drospirenone in extended-cycle regimens: population pharmacokinetic analysis from a randomised Phase III study.延长周期方案中炔雌醇和屈螺酮的药代动力学特征:一项随机III期研究的群体药代动力学分析
J Fam Plann Reprod Health Care. 2013 Apr;39(2):e1-13. doi: 10.1136/jfprhc-2012-100397.
9
Long-term tolerability of ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen: results from a randomised, controlled, multicentre study.炔雌醇20μg/屈螺酮3mg灵活延长疗程的长期耐受性:一项随机、对照、多中心研究的结果
J Fam Plann Reprod Health Care. 2012 Apr;38(2):84-93. doi: 10.1136/jfprhc-2011-100214.
10
Contraceptive efficacy and tolerability of ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen: an open-label, multicentre, randomised, controlled study.炔雌醇20μg/屈螺酮3mg灵活延长方案的避孕效果及耐受性:一项开放标签、多中心、随机对照研究
J Fam Plann Reprod Health Care. 2012 Apr;38(2):73-83. doi: 10.1136/jfprhc-2011-100213.